Cardiac sympathetic denervation in Parkinson's disease patients with SWEDDs

Neurological Sciences

Volumn 34, Issue 8, 2013, Pages 1375-1382

  Jang, Wooyoung ^a   Kim, Joong Seok ^b   Cho, Jin Whan ^c   Kim, Young Hwan ^d   Kim, Ji Young ^d   Choi, Yun Young ^d   Kim, Hee Tae ^a  

^a Hanyang University   (South Korea)

^b The Catholic University of Korea College of Medicine   (South Korea)

^c Samsung Medical Center   (South Korea)

^d Hanyang University College of Medicine   (South Korea)

Author keywords

123I MIBG scintigraphy; FP CIT PET; Parkinson's disease; SWEDDs

Indexed keywords

(3 IODOBENZYL)GUANIDINE I 131; DOPAMINE TRANSPORTER; LEVODOPA;

ADULT; AGED; ARTICLE; BRADYKINESIA; BRAIN REGION; CAUDATE NUCLEUS; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CLINICAL FEATURE; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONTROLLED STUDY; DISEASE COURSE; DYSTONIA; FEMALE; HEART DENERVATION; HUMAN; MALE; PARKINSON DISEASE; PUTAMEN; RADIOLOGICAL PARAMETERS; SCAN WITHOUT EVIDENCE OF DOPAMINERGIC; STRIATE CORTEX;

3-IODOBENZYLGUANIDINE; AGED; AGED, 80 AND OVER; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; FEMALE; HEART; HUMANS; MALE; MIDDLE AGED; PARKINSON DISEASE; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; SYMPATHETIC NERVOUS SYSTEM;

EID: 84883190726     PISSN: 15901874     EISSN: 15903478     Source Type: Journal    
DOI: 10.1007/s10072-012-1244-1     Document Type: Article

References (24)

1. Spiegel J, Möllers M-O, Jost WH, Fuss G, Samnick S, Dillmann U, Becker G, Kirsch C-M (2005) FP-CIT and MIBG scintigraphy in early Parkinson's disease. Mov Disord 20(5):552-561
2. 123I-metaiodobenzylguanidine scintigraphy in Parkinson's disease and related disorders. Mov Disord 24(S2):S732-S741
3. Winogrodzka A, Bergmans P, Booij J, van Royen EA, Stoof JC, Wolters EC (2003) [123I]β-CIT SPECT is a useful method for monitoring dopaminergic degeneration in early stage Parkinson's disease. J Neurol Neurosurg Psychiatry 74(3):294-298
4. Marek K, Seibyl J, Parkinson Study Group (2008) Beta-CIT scans without evidence of dopaminergic deficit(SWEDD) in the ELLDOPA-CIT and CALM-CIT studies: long-term imaging assessment. Neurology 60(Suppl 1):A293
5. Whone AL, Watts RL, Stoessl AJ, Davis M, Reske S, Nahmias C, Lang AE, Rascol O, Ribeiro MJ, Remy P, Poewe WH, Hauser RA, Brooks DJ (2003) Slower progression of Parkinson's disease with ropinirole versus levodopa: The REAL-PET study. Ann Neurol 54(1):93-101
6. Schneider SA, Edwards MJ, Mir P, Cordivari C, Hooker J, Dickson J, Quinn N, Bhatia KP (2007) Patients with adult-onset dystonic tremor resembling Parkinsonian tremor have scans without evidence of dopaminergic deficit (SWEDDs). Mov Disord 22(15):2210-2215
7. Schwingenschuh P, Ruge D, Edwards MJ, Terranova C, Katschnig P, Carrillo F, Silveira-Moriyama L, Schneider SA, Kägi G, Palomar FJ, Talelli P, Dickson J, Lees AJ, Quinn N, Mir P, Rothwell JC, Bhatia KP (2010) Distinguishing SWEDDs patients with asymmetric resting tremor from Parkinson's disease: a clinical and electrophysiological study. Mov Disord 25(5):560-569
8. Druschky A, Hilz MJ, Platsch G, Radespiel-Tröger M, Druschky K, Kuwert T, Neundörfer B (2000) Differentiation of Parkinson's disease and multiple system atrophy in early disease stages by means of I-123-MIBG-SPECT. J Neurol Sci 175(1):3-12
9. Orimo S, Takahashi A, Uchihara T, Mori F, Kakita A, Wakabayashi K, Takahashi H (2007) Degeneration of cardiac sympathetic nerve begins in the early disease process of Parkinson's disease. Brain Pathol 17(1):24-30
10. Gasser T, Schwarz J, Arnold G, Trenkwalder C, Oertel WH (1992) Apomorphine test for dopaminergic responsiveness in patients with previously untreated Parkinson's disease. Arch Neurol 49(11):1131-1134
11. Park HK, Kim JS, Im KC, Oh SJ, Kim MJ, Lee J-H, Chung SJ, Lee MC (2009) Functional brain imaging in pure akinesia with gait freezing: [18F] FDG PET and [18F] FP-CIT PET analyses. Mov Disord 24(2):237-245
12. Mozley PD, Kim H-J, Gur RC, Tatsch K, Muenz LR, McElgin WT, Kung M-P, Mu M, Myers AM, Kung HF (1996) Iodine-123-IPT SPECT imaging of CNS dopamine transporters: nonlinear effects of normal aging on striatal uptake values. J Nucl Med 37(12):1965-1970
13. Bain PG (2009) Dystonic tremor presenting as Parkinsonism: long-term follow-up of SWEDDs. Neurology 72(16):1443-1445
14. Mian OS, Schneider SA, Schwingenschuh P, Bhatia KP, Day BL (2011) Gait in SWEDDs patients: comparison with Parkinson's disease patients and healthy controls. Mov Disord 26(7):1266-1273
15. Silveira-Moriyama L, Schwingenschuh P, O'Donnell A, Schneider SA, Mir P, Carrillo F, Terranova C, Petrie A, Grosset DG, Quinn NP, Bhatia KP, Lees AJ (2009) Olfaction in patients with suspected Parkinsonism and scans without evidence of dopaminergic deficit (SWEDDs). J Neurol Neurosurg Psychiatry 80(7):744-748
16. Sixel-Döring F, Liepe K, Mollenhauer B, Trautmann E, Trenkwalder C (2011) The role of 123I-FP-CIT-SPECT in the differential diagnosis of Parkinson and tremor syndromes: a critical assessment of 125 cases. J Neurol 258(12):2147-2154
17. Hall DA, Jennings D, Seibyl J, Tassone F, Marek K (2010) FMR1 gene expansion and scans without evidence of dopaminergic deficits in Parkinsonism patients. Parkinsonism Relat Disord 16(9):608-611
18. Bajaj NPS, Gontu V, Birchall J, Patterson J, Grosset DG, Lees AJ (2010) Accuracy of clinical diagnosis in tremulous Parkinsonian patients: a blinded video study. J Neurol Neurosurg Psychiatry 81(11):1223-1228
19. Deuschl G, Bain P, Brin M (1998) Consensus statement of the movement disorder society on tremor. Mov Disord 13(S3):2-23
20. Fasano A, Baldari S, Di Giuda D, Paratore R, Piano C, Bentivoglio AR, Girlanda P, Morgante F (2012) Nigro-striatal involvement in primary progressive freezing gait: insights into a heterogeneous pathogenesis. Parkinsonism Relat Disord 18(5):578-584
21. Chung EJ, Lee WY, Yoon WT, Kim BJ, Lee GH (2009) MIBG scintigraphy for differentiating Parkinson's disease with autonomic dysfunction from Parkinsonism-predominant multiple system atrophy. Mov Disord 24(11):1650-1655
22. Ishibashi K, Saito Y, Murayama S, Kanemaru K, Oda K, Ishiwata K, Mizusawa H, Ishii K (2010) Validation of cardiac 123I-MIBG scintigraphy in patients with Parkinson's disease who were diagnosed with dopamine PET. Eur J Nucl Med Mol Imaging 37(1):3-11
23. Südmeyer M, Antke C, Zizek T, Beu M, Nikolaus S, Wojtecki L, Schnitzler A, Müller H-W (2011) Diagnostic accuracy of combined FP-CIT, IBZM, and MIBG scintigraphy in the differential diagnosis of degenerative Parkinsonism: a multidimensional statistical approach. J Nucl Med 52(5):733-740
24. Nagayama H, Hamamoto M, Ueda M, Nagashima J, Katayama Y (2005) Reliability of MIBG myocardial scintigraphy in the diagnosis of Parkinson's disease. J Neurol Neurosurg Psychiatry 76(2):249-251